Alice Miranda-Olstein

So what was really striking is, you know, the Supreme Court was like, okay, we're going to, you know, step in here and at least decide this case on a temporary basis.

And they heard from Louisiana.

They heard from the drug makers.

Louisiana's complaint should have been dismissed outright.

They heard from all of these other people, members of Congress.

Brief for 259 members of Congress as amici... Governors.

activist groups on all sides.

Many religious traditions view abortion as morally acceptable.

Former FDA officials.

FDA was extremely cautious in approving nifepristone.

Everybody was sending briefs up to the Supreme Court.

But you know who didn't?

The Trump administration.

The Trump administration... The guy who talks about everything didn't say anything?

Did not weigh in.

Did not either ask the Supreme Court to maintain the status quo or side with Louisiana.

They were silent.

The FDA has said it, you know, is reviewing the safety of the pills and will make its own decision.

So the Trump administration had told lower courts, hey, back off, you know, let the FDA do its thing.

But now that the case is before the Supreme Court...